000 | 01180 a2200325 4500 | ||
---|---|---|---|
005 | 20250514185940.0 | ||
264 | 0 | _c20050208 | |
008 | 200502s 0 0 eng d | ||
022 | _a0303-7207 | ||
024 | 7 |
_a10.1016/j.mce.2003.10.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGarthwaite, Susan M | |
245 | 0 | 0 |
_aThe evolution of aldosterone antagonists. _h[electronic resource] |
260 |
_bMolecular and cellular endocrinology _cMar 2004 |
||
300 |
_a27-31 p. _bdigital |
||
500 | _aPublication Type: Historical Article; Journal Article | ||
650 | 0 | 4 |
_aAldosterone _xhistory |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aEplerenone |
650 | 0 | 4 |
_aGynecomastia _xdrug therapy |
650 | 0 | 4 | _aHistory, 20th Century |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xchemical synthesis |
650 | 0 | 4 |
_aSpironolactone _xanalogs & derivatives |
700 | 1 | _aMcMahon, Ellen G | |
773 | 0 |
_tMolecular and cellular endocrinology _gvol. 217 _gno. 1-2 _gp. 27-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mce.2003.10.005 _zAvailable from publisher's website |
999 |
_c14844377 _d14844377 |